Drug profile · INN
pancrelipase (amylase
PERTZYE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pancrelipase (amylase (PERTZYE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pancrelipase (amylase
Brand PERTZYE
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is pancrelipase (amylase?
pancrelipase (amylase (PERTZYE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pancrelipase (amylase?
PERTZYE is a marketed brand name for pancrelipase (amylase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pancrelipase (amylase?
pancrelipase (amylase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.